Adverse Event. Adverse Event Status. version date: 12/10/ of 21. Please enter the date of the event you are reporting:

Similar documents
Adverse Event. Adverse Event Status. Please enter the date of the event you are reporting: Please enter a label describing this event:

Adverse Event - Pedimacs

Adverse Event - Intermacs

Adverse Event Not Started

Yes No Unknown. Major Infection Information

Yes No Unknown. In hospital Out of hospital Unknown. Blood Pump Drive Unit Failure External Control System Failure. Yes No Unknown

HeartWare ADVANCE Bridge to Transplant Trial and Continued Access Protocol Update

1 Week Followup - Intermacs

1 Week Followup 5/27/2014. Nursing Home/Assisted Care Hospice Another hospital Rehabilitation Facility Unknown

Followup Status (1 Week Followup (+/- 3 days))

HEARTMATE 3 LEFT VENTRICULAR ASSIST SYSTEM

Alliance A Symptomatic brain radionecrosis after receiving radiosurgery for

ECLS Registry Form Extracorporeal Life Support Organization (ELSO)

HEARTMATE 3 LVAD WITH FULL MAGLEV FLOW TECHNOLOGY THEIR FUTURE STARTS WITH YOU

EACTS Adult Cardiac Database

GWTG Post-Discharge Follow-up Form

Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with HeartMate 3 (MOMENTUM 3) Long Term Outcomes

Inpatient Outpatient Other Facility Unable to obtain follow up information

The Balancing Act Bleeding and Thrombosis in MCS. Muhammad Adil Soofi

Online Supplementary Data. Country Number of centers Number of patients randomized

TAVR : Caring for your patients before and after TAVR

Modern Left Ventricular Assist Devices (LVAD) : An Intro, Complications, and Emergencies

STATE OF OKLAHOMA 2014 EMERGENCY MEDICAL SERVICES PROTOCOLS

CEREBRO VASCULAR ACCIDENTS

1 Month Followup - Pedimacs

Left Ventricular Assist Devices LVAD. North Country EMS Program Agency 3/21/12

University of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives

Destination Therapy SO MUCH DATA IN SUCH A SMALL DEVICE. HeartWare HVAD System The ONLY intrapericardial VAD approved for DT.

1/21/2016. HeartMate II Indications for Use. Ventricular Assist Device Overview. Jon G. Echterling MSN, CCRN, FNP-BC. Learning Objectives

Medical Review Guidelines Magnetic Resonance Angiography

LIVING A MORE ACTIVE LIFE. with the HeartMate 3 LVAD for the treatment of advanced heart failure RON. Recipient

Venous Thromboembolism Prophylaxis

NCDR CARE Registry Carotid Artery Revascularization and Endarterectomy Registry Carotid Artery Stenting Form v1.09

Cardiothoracic and Cardiothoracic Surgery ICD-10-CM 2014: Reference Mapping Card

Anticoagulants and Head Injuries. Asaad Shujaa,MD,FRCPC,FAAEM Assistant Professor,weill Corneal Medicne Senior Consultant,HMC Qatar

Dental Management Considerations for Patients on Antithrombotic Therapy

Complications of Left Ventricular Assist Device Chronic Support. Dr. Tal Hasin RMC, Beilinson, Petach-Tiqva, Israel

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER:

Appendix Criteria used for the automated chart review

Asif Serajian DO FACC FSCAI

Acute Coronary Syndrome

From A to Z-Codes Matter

4. Which survey program does your facility use to get your program designated by the state?

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

EMS and Nursing Considerations in VAD Patient Care

Supplement Table 1. Definitions for Causes of Death

LVAD Complications, Recovery

A Fully Magnetically Levitated Left Ventricular Assist Device. Final Report of the MOMENTUM 3 Trial

Episodes of Care Risk Adjustment

Nov FromAtoZCodesMatter

How to mend a broken heart: transplantation or LVAD?

A Great Clinical Paradox. Narendranath Epperla MD Sowjanya Bapani MD Steven Yale MD, FACP

Index. Hematol Oncol Clin N Am 19 (2005) Note: Page numbers of article titles are in boldface type.

Watchman and Structural update..the next frontier. Ari Chanda, MD Cardiology Associates of Fredericksburg

Appropriate Use Criteria for Initial Transthoracic Echocardiography in Outpatient Pediatric Cardiology (scores listed by Appropriate Use rating)

The following content was supplied by the author as supporting material and has not been copy-edited or verified by JBJS.

Cardiac Pathology & Rehabilitation

Intensive Medical Therapy with Therapeutic Hypothermia for Malignant Middle Cerebral Artery Infarction

Mechanical Support in the Failing Fontan-Kreutzer

Appendix. Potentially Preventable Complications (PPCs) identify. complications that can occur during an admission. There are 64

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service

EMS: Care of the VAD Patient. Brittany Butzler BSN RN VAD Coordinator Froedtert and the Medical College of WI

SAMPLE Data Entry Manual for the veds Project

Prescribe appropriate immunizations for. Prescribe childhood immunization as per. Prescribe influenza vaccinations in high-risk

Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine

Long Term Follow-up. 6 Month 1 Year Annual enter year #: What is the assessment date: / / Unknown. Is the patient alive? Yes No

New Jersey Cardiac Catheterization Data Registry, Version 2.0 (Please report data only for patients 16 years or older.)

Risk Factors for Adverse Outcome after HeartMate II Jennifer Cowger, MD, MS St. Vincent Heart Center of Indiana

Diagnosis of Device Thrombosis

Heart Valves: Before and after surgery

Should We Reconsider using Anticoagulation for Biological Tissue Valves

NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS. ACTIVASE (t-pa) INFUSION PROTOCOL FOR ACUTE MYOCARDIAL INFARCTION

HeartMate 3 Left Ventricular Assist System Catalog #106524US LVAS KIT, HM3

Recent Trials With Durable LVADs: Is There a Superior Device?

Hu J, Gonsahn MD, Nerenz DR. Socioeconomic status and readmissions: evidence from an urban teaching hospital. Health Aff (Millwood). 2014;33(5).

Index. Note: Page numbers of article titles are in boldface type.

Safety Evaluation of the Pericardial HeartWare MVAD System

Analysis of Pump Thrombosis in the Intermacs Database

Crosswalk File of ICD9 Diagnosis Codes to Risk Group Assignment 1-Apr-15

Supplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1.

(For items 1-12, each question specifies mark one or mark all that apply.)

Index. Note: Page numbers of article titles are in boldface type.

Complications of Acute Myocardial Infarction

Imaging abdominal vascular emergencies. V.Stoynova

NCDR CathPCI Registry v4.4 Diagnostic Catheterization and Percutaneous Coronary Intervention Registry

WARFARIN: PERI-OPERATIVE MANAGEMENT

Atrial Fibrillaiton and Heart Failure: Anticoagulation therapy in all cases?

New Antithrombotic and Antiplatelet Drugs in CAD : (Factor Xa inhibitors, Direct Thrombin inhibitors and Prasugrel)

DRG Code DRG Description FY18 Average Charge

NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS. ACUTE CEREBROVASCULAR ACCIDENT TPA (ACTIVASE /alteplase) FOR THROMBOLYSIS

ICD-10 Physician Education. Palliative Care SIP

Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.

/ / / / / / Hospital Abstraction: Stroke/TIA. Participant ID: Hospital Code: Multi-Ethnic Study of Atherosclerosis

Stroke 101. Maine Cardiovascular Health Summit. Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013

Nilotinib AEs (adverse events) in CML population:

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE. Cranial Health History Form

NCDR AFib Ablation Registry v1.0 Atrial Fibrillation (AF) Ablation Interventional Registry

WARFARIN: PERI OPERATIVE MANAGEMENT

Transcription:

version date: 12/10/2015 Adverse Event Adverse Event Status Please enter the date of the event you are reporting: Please enter a label describing this event: 1 of 21

version date: 12/10/2015 Adverse Event Rehospitalization Was there an occurrence of rehospitalization? Date of admission Discharge Date Primary reason for rehospitalization Anticoagulation adjustment Arterial n CNS Thrombo embolism Cardiac Arrhythmia Cardiac Tamponade Catastrophe (i.e. weather) Device Malfunction Diagnostic Procedure Explant Fever without known cause Fluid Overload Gastroenteritis GI Disorder Hematological Hematoma Hemolysis Hepatic Dysfunction Hypertension Limb vascular complication Major Bleeding Major Infection Metabolic/Electrolyte Disturbance Myocardial Infarction Neurological Dysfunction Pericardial Fluid Collection Planned medical management Planned Procedure Pneumonia Psychiatric Episode Pulmonary Embolism/Hemorrhage Pulmonary, Other Renal Dysfunction Respiratory Failure Right Heart Failure Social Issues / Disposition (Foster Care / Eviction) Syncope without known cause Transplant Trauma/Accident 2 of 21

Adverse Event - Rehospitalization version date: 12/10/2015 Venous Thromboembolic Event Wound Complication Wound Dehiscence Rehospitalization intervention ne Transplantation Surgical Procedure Heart Cath Invasive Cardiac Procedures (Other than Heart Cath) Other Type of surgical procedure Device related operation Other Cardiac Surgical Procedure n Cardiac Surgical Procedure Other procedure Type of other cardiac procedure Reoperation for Bleeding within 48 hours of implant Reoperation for Bleeding and/or tamponade > 48 hours Surgical Drainage of pericardial effusion Aortic Valve Surgery Repair (no valve closure) Aortic Valve Surgery Repair with valve closure Aortic Valve Surgery Replacement Biological Aortic Valve Surgery Replacement Mechanical Mitral Valve Surgery Repair Mitral Valve Surgery Replacement Biological Mitral Valve Surgery Replacement Mechanical Tricuspid Valve Surgery Repair DeVega Tricuspid Valve Surgery Repair Ring Tricuspid Valve Surgery Repair Other Tricuspid Valve Surgery Replacement Biological Tricuspid Valve Surgery Replacement Mechanical Pulmonary Valve Surgery Repair Pulmonary Valve Surgery Replacement Biological Pulmonary Valve Surgery Replacement Mechanical Type of procedure (non cardiac surgical procedure) Other procedure Intubation and Vent support Dialysis Bronchoscopy Type of Invasive Cardiac Procedure (Other than Heart Cath) Enter PA systolic pressure mmhg t Done 3 of 21

Adverse Event - Rehospitalization version date: 12/10/2015 Enter PA diastolic pressure mmhg t Done Enter PCW pressure mmhg t Done Enter Cardiac output L/min t Done Clinical Observations Systolic blood pressure t done mmhg Diastolic blood pressure t done mmhg Mean Arterial Blood Pressure (MAP) mmhg t done Did patient receive new IV or oral medications to treat hypertension? Has the patient experienced a Neurological Event since time of implant? If yes, provide Modified Rankin Scale: 0 symptoms at all 1 Significant disability: despite symptoms: able to carry out all usual duties and activities 2 Slight disability: unable to carry out all previous activities but able to look after own affairs without assistance 3 Moderate disability: requiring some help, but able to walk without assistance. 4 Moderately severe disability: unable to walk without assistance, and unable to attend to own bodily needs without assistance. 5 Severe disability: bedridden, incontinent and requiring constant nursing care and attention. 6 Dead t Documented t Done Please click here for further instruction on administering the Modified Rankin Scale in Appendix I. 4 of 21

version date: 12/10/2015 Adverse Event Infection Was there a major infection? Date of onset Did this infection contribute to death? Location of patient In hospital Out of hospital Location of infection Pump / related Drive Line Pump / related Exit Cannula Pump / related Pump Pocket Pump / related Pump Interior Positive Blood cultures Line Sepsis Pulmonary Urinary Tract Mediastinum Peripheral Wound GI Type of infection Bacterial Fungal Viral Protozoan Intervention Drug therapy only: Oral Drug therapy only: IV Surgical and drug therapy Surgical therapy only Is this a Device Related Event? 5 of 21

version date: 12/10/2015 Adverse Event Bleeding (Transfusions for anemia and hemolysis are not considered bleeding events) Was there a Major Bleeding Event? Date of bleeding episode onset Location of patient In hospital Out of hospital Did the major bleeding episode result in one or more of the following Episode resulted in Death Episode resulted in re intervention Episode resulted in hospitalization Episode resulted in transfusion Total units PRBC's (Enter total number of cc's received for this bleeding episode) Date of first transfusion for this episode Source/cause/location of bleeding Mediastinal: chest wall Mediastinal: outflow aorta anastomosis Mediastinal: outflow conduit Mediastinal: inflow conduit Mediastinal: aortic venous cannulation site Mediastinal: coagulopathy with no surgical site Mediastinal: other surgical site Pump pocket Pleural space Intra abdominal Retroperitoneal Pulmonary Device anastamosis Urinary tract GI: Upper gastrointestinal (esophagus, stomach, duodenum, small bowel) GI: Lower gastrointestinal (colon, rectum, and anus) GI: unknown, but guaiac positive stools Heparin levels t Done INR 6 of 21

Adverse Event - Bleeding version date: 12/10/2015 t Done Anticoagulant therapy at time of event Warfarin Heparin Lovenox Aspirin Dipyridamole Clopidogrel (plavix) Argatroban Bivalirudin Fondaparinux Dextran Ticlopidine Hirudin Lepirudin Ximelagatran ne Is this a Device Related Event? 7 of 21

version date: 12/10/2015 Adverse Event Neuro Was there a neurological dysfunction? Date of onset Location of patient In hospital Out of hospital Neurological dysfunction categories Type of CVA Stroke severity TIA CVA Seizure Encephalopathy Infarction Seen by Imaging, without Clinical Findings of TIA/Stroke Extra axial Bleeding Seen by imaging study Confusion ne Ischemic / Embolism Hemorrhagic Other Left sided weakness Right sided weakness Left sided paralysis Right sided paralysis Speech deficit Altered mental status Coma Is this a Device Related Event? Seizure Type Encephalopathy type Generalized Focal Metabolic Anoxic Traumatic Other Did this Neurological Dysfunction Adverse Event contribute to the patient's death? 8 of 21

Adverse Event - Neurological Dysfunction version date: 12/10/2015 Location of CNS event Right hemisphere: frontal Right hemisphere: temporal Right hemisphere: occipital Right hemisphere: parietal Right hemisphere: unspecified Left hemisphere: frontal Left hemisphere: temporal Left hemisphere: occipital Left hemisphere: parietal Left hemisphere: unspecified Bilateral: frontal Bilateral: temporal Bilateral: occipital Bilateral: parietal Occipital Brain stem Cerebellar Thalamic Subdural Spinal cord Method of diagnosis of CNS event CT MRI Angiogram Clinical EEG Ultrasound Anticoagulant therapy at time of event Warfarin Heparin Lovenox Aspirin Dipyridamole Clopidogrel (plavix) Argatroban Bivalirudin Fondaparinux Dextran Ticlopidine Hirudin Lepirudin Ximelagatran ne Hypertension Has the patient experienced a 9 of 21

Adverse Event - Neurological Dysfunction version date: 12/10/2015 Neurological Event since time of implant? If yes, provide Modified Rankin Scale: 0 symptoms at all 1 Significant disability 2 Slight disability 3 Moderate disability 4 Moderately severe disability 5 Severe disability 6 Dead t Documented t Done 10 of 21

version date: 12/10/2015 Adverse Event Device Malf/Failure and/or Pump Thrombus Was there a device malfunction / failure and / or a pump thrombus? Date of onset Device Type Location of patient In hospital Out of hospital Description of Malfunction Thrombus Event Did the patient experience a thrombus event (suspected or confirmed)? Was the suspected or confirmed thrombus associated with one or more of the following signs or symptoms? Hemolysis Heart Failure Abnormal Pump Parameters Stroke TIA Arterial n CNS Thromboembolism ne Other, Specify Did the patient have one or more of the following? Treatment with intravenous anticoagulation (e.g. heparin) Intravenous thrombolytic (e.g. TPA) Intravenous antiplatelet therapy (e.g. eptifibatide) Other, Specify Was the thrombus event confirmed? Please select method of confirmation: Imaging Study Visual Inspection Manufacturer's Report 11 of 21

Adverse Event - Device Malf/Failure and/or Pump Thrombus version date: 12/10/2015 Was there a device Malfunction? Pump Please select all of the components that apply Pump Component(s) Pump Body (including bearings and rotor) Driveline Inflow Cannula Outflow Graft (including bend relief) Controller Controller Primary System Failure (running in backup mode) Complete System Failure (primary and backup failure) Power Cable (attached to controller) Power Connectors (attached to controller) Peripherals Peripheral Component(s) External Battery Cell Battery (in controller) Power Module Patient Cable System Monitor / Display Battery Charger Battery Clip Pump (RVAD) Pump Component(s) (RVAD) Pump Body (including bearings and rotor) Driveline Inflow Cannula Outflow Graft (including bend relief) Controller (RVAD) Controller Component(s) (RVAD) Primary System Failure (running in backup mode) Complete System Failure (primary and backup failure) Power Cable (attached to controller) Power Connectors (attached to controller) Peripherals (RVAD) Peripheral Component(s) (RVAD) External Battery Cell Battery (in controller) Power Module Patient Cable System Monitor / Display Battery Charger Battery Clip 12 of 21

Adverse Event - Device Malf/Failure and/or Pump Thrombus version date: 12/10/2015 Outcomes of Device Adverse Event Patient Outcome Death Serious Injury Urgent Transplantation Explant Without Replacement Exchange Breach of Integrity of Drive Line that Required Repair Other Surgical Procedure ne of the Above Causative or contributing factors to the Device Malfunction Patient Accident Patient n Compliance Sub Therapeutic Anticoagulation Prothrombotic States End of Component Expected Life Technical/Procedural Issues (e.g. cannula or graft malposition or kinking) Cause Identified 13 of 21

version date: 12/10/2015 Adverse Event Additional Adverse Events Were there any additional adverse events? Cardiac Arrhythmia Event Date Type of cardiac arrhythmia Sustained ventricular arrhythmia requiring defibrillation or cardioversion Sustained supraventricular arrhythmia requiring drug treatment or cardioversion Pericardial Effusion Event Date Signs of tamponade Method of drainage OP Cath Hepatic Dysfunction Total bilirubin measurement mg/dl t Done SGOT / AST measurement u/l t Done SGPT / ALT measurement u/l Event Date t Done 14 of 21

Adverse Event - Additional Adverse Events version date: 12/10/2015 Myocardial Infarction Event Date Psychiatric Episode Event Date Renal Dysfunction Event Date Dialysis duration days t Done Ongoing Peak creatinine measurement mg/dl t Done Respiratory Failure Event Date Ongoing Intubation duration days Ongoing Was a tracheotomy performed? Arterial n CNS Thromboembolism 15 of 21

Adverse Event - Additional Adverse Events version date: 12/10/2015 Date Location Pulmonary Renal Hepatic Splenic Limb Other Confirmation source Standard clinical and laboratory testing Operative findings Autopsy finding Other Anticoagulant therapy at time of event Warfarin Heparin Lovenox Aspirin Dipyridamole Clopidogrel (plavix) Argatroban Bivalirudin Fondaparinux Dextran Ticlopidine Hirudin Lepirudin Ximelagatran ne Venous Thromboembolism Event Deep Vein thrombosis Pulmonary Embolus ne Enter deep vein thrombosis date Enter pulmonary embolus date Enter other date 16 of 21

Adverse Event - Additional Adverse Events version date: 12/10/2015 Anticoagulant therapy at time of event Warfarin Heparin Lovenox Aspirin Dipyridamole Clopidogrel (plavix) Argatroban Bivalirudin Fondaparinux Dextran Ticlopidine Hirudin Lepirudin Ximelagatran ne Wound Dehiscence Date Enter location: Sternum Driveline Sites Site of thoracotomy Other Events Description Event Date 17 of 21

version date: 12/10/2015 Adverse Event Explant Explant: For Device Exchange, Recovery, or Transplant Explant date Device explanted LVAD RVAD BIVAD TAH Explant reason Transplant Device Malfunction Elective Device Malfunction Emergent Device Thrombosis Elective Device Thrombosis Emergent Infection Emergent Infection Elective Ventricular Recovery Device removed Ventricular Recovery Device not removed but turned off Device removed (or turned off) for reasons other than recovery, transplant, or death, Specify Transplant date Waitlist ID Pump Thrombosis Exchanged Device FDA IDE Trial Name of FDA IDE Trial 18 of 21

version date: 12/10/2015 Adverse Event Death Did the patient die? Death date Was device functioning normally? Associated Operation Post mortem device explant? Did the device go to the manufacturer? Location of death In hospital Long term care facility Home/Residence Out of hospital, Other 19 of 21

Adverse Event - Death version date: 12/10/2015 Primary cause of death Respiratory: Venous Thromboembolism Event Respiratory: Respiratory Failure Respiratory: Pulmonary: Circulatory: Arterial n CNS Thromboembolism Circulatory: Myocardial Infarction Circulatory: Myocardial Rupture Circulatory: Ruptured Aortic aneurysm Circulatory: Right Heart Failure Circulatory: Major Bleeding Circulatory: Cardiac Arrhythmia Circulatory: Hemolysis Circulatory: Hypertension Circulatory: Other, Specify Circulatory: Sudden unexplained death Circulatory: CHF Circulatory: Heart Disease Circulatory: End Stage Cardiomyopathy Circulatory: End Stage Ischemic Cardiomyopathy Circulatory: Pericardial Fluid Collection (effusion) Digestive (Intestinal or GI/GU): Hepatic Dysfunction Digestive (Intestinal or GI/GU): Renal Dysfunction Digestive (Intestinal or GI/GU): GI Disorder Digestive (Intestinal or GI/GU): Fluid/Electrolyte Disorder Digestive (Intestinal or GI/GU): Pancreatitis Nervous System: Neurological Dysfunction Psychiatric Episode/Suicide Major Infection Device Malfunction Multiple System Organ Failure (MSOF) Withdrawal of Support, specify Cancer Wound Dehiscence Trauma/accident, specify Endocrine Hematological Select type of cancer CNS GI Lymph ENT Pulmonary Renal Breast Reproductive Skin Other Specify support withdrawn 20 of 21

Adverse Event - Death version date: 12/10/2015 Specify 21 of 21